These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2019 related articles for article (PubMed ID: 33942579)

  • 21. DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination.
    Casucci G; Acanfora D
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34205940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.
    Kitagawa H; Kaiki Y; Sugiyama A; Nagashima S; Kurisu A; Nomura T; Omori K; Akita T; Shigemoto N; Tanaka J; Ohge H
    J Infect Chemother; 2022 Apr; 28(4):576-581. PubMed ID: 35058126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse reactions and production of neutralizing anti-SARS-CoV-2 antibodies after ChAdOx1 COVID-19 vaccination: A cross-sectional study in a single center.
    Jeong YJ; Kim YJ; Kim SH; Yoo J; Lee J; Lee S; Il Kim S
    J Infect Public Health; 2022 Mar; 15(3):360-364. PubMed ID: 35193817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.
    Sah MK; Singh BM; Sinha P; Devkota P; Yadav SK; Shrestha J; Shrestha A
    J Med Case Rep; 2022 May; 16(1):182. PubMed ID: 35524323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea.
    Kwon Y; Hwang I; Ko M; Kim H; Kim S; Seo SY; Cho E; Lee YK
    Epidemiol Health; 2023; 45():e2023006. PubMed ID: 37183320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine Side Effects in Health Care Workers after Vaccination against SARS-CoV-2: Data from TüSeRe:exact Study.
    Bareiß A; Uzun G; Mikus M; Becker M; Althaus K; Schneiderhan-Marra N; Fürstberger A; Schwab JD; Kestler HA; Holderried M; Martus P; Schenke-Layland K; Bakchoul T
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 vaccination in people with multiple sclerosis, real-life experience.
    Alroughani R; Al-Hashel J; Abokalawa F; AlMojel M; Farouk Ahmed S
    Clin Neurol Neurosurg; 2022 Sep; 220():107374. PubMed ID: 35961255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of adaptive immune responses in healthcare workers who received a Coronavirus disease 2019 vaccine booster dose.
    Klinmalai C; Srisala S; Sahakijpicharn T; Apiwattanakul N
    Health Sci Rep; 2024 Jul; 7(7):e2250. PubMed ID: 39015422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.
    Kadali RAK; Janagama R; Peruru S; Malayala SV
    Int J Infect Dis; 2021 May; 106():376-381. PubMed ID: 33866000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
    Song JY; Cheong HJ; Kim SR; Lee SE; Kim SH; Noh JY; Yoon YK; Choi WS; Park DW; Sohn JW; Kim WJ; Kim MJ
    J Korean Med Sci; 2021 Apr; 36(15):e110. PubMed ID: 33876589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination.
    Lim SY; Kim JY; Park S; Kwon JS; Park JY; Cha HH; Suh MH; Lee HJ; Lim JS; Bae S; Jung J; Lee N; Kim K; Shum D; Jee Y; Kim SH
    Immune Netw; 2021 Dec; 21(6):e41. PubMed ID: 35036028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021.
    Fortunato F; Prato R; Iannelli G; Ascatigno L; Loconsole D; Lopalco PL; Martinelli D
    Hum Vaccin Immunother; 2023 Dec; 19(1):2209919. PubMed ID: 37226552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    Rayamajhi S; Rafi MA; Tripathi N; Dongol AS; Pandey M; Rayamajhi S; Bhandari S; Shrestha P; Hasan MT; Hossain MG
    PLoS One; 2022; 17(8):e0272729. PubMed ID: 35947626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus and RNA-based COVID-19 vaccines' perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey.
    Temsah MH; Barry M; Aljamaan F; Alhuzaimi A; Al-Eyadhy A; Saddik B; Alrabiaah A; Alsohime F; Alhaboob A; Alhasan K; Alaraj A; Halwani R; Alamro NM; Al-Shahrani FS; Jamal A; Alsubaie S; Memish ZA; Al-Tawfiq JA
    BMJ Open; 2021 Jun; 11(6):e048586. PubMed ID: 34155080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala.
    Jose M; Rajmohan P; Thomas J; Krishna S; Antony B; Gopinathan UU; Iyyapan EM; Porinchu RM; Jose P; Raphael L; Kuttichira P
    Curr Drug Saf; 2022; 17(4):327-334. PubMed ID: 35135453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impacts of Side Effects to BNT162b2 and the First Dose of ChAdOx1 Anti-SARS-CoV-2 Vaccination on Work Productivity, the Need for Medical Attention, and Vaccine Acceptance: A Multicenter Survey on Healthcare Workers in Referral Teaching Hospitals in the Republic of Korea.
    Kim T; Park SY; Yu S; Park JW; Lee E; Jeon MH; Kim TH; Choo EJ
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34198562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 101.